Studies have shown that starting a high-efficacy DMT like Tysabri earlier in the disease course can also lead to less ...

Bullish option flow detected in Biogen (BIIB) with 2,540 calls trading, 1.1x expected, and implied vol increasing over 2 points to 35.32%.

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a ...

Emmerdale fans have "rumbled" the blackmailer behind Manpreet's mysterious texts as they're convinced a character set to exit the soap this year is guilty. Rebecca Sarker first stepped foot in the ...

ICON is a strong player in the CRO industry demonstrating ... adding to consumer discretionary where we have recently had less exposure. We exited Biogen (BIIB), a biotechnology company developing ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark.

The Estate Golden Grove Great House, which was the residence of A.J. Blackwood who once owned Estate Adventure, which is located next to Estate Golden Grove. It was built by enslaved Africans more ...

Health regulators in Canada gave conditionally approval to Qalsody to treat adults whose ALS is due to mutations in the SOD1 gene.

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Leerink ...

High-rolling investors have positioned themselves bullish on Biogen (NASDAQ:BIIB), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...